JPMorgan Chase & Co’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6 | Hold |
4
| – | – | ﹤0.01% | 6108 |
|
|
2025
Q1 | $4 | Sell |
4
-85,798
| -100% | -$85.8K | ﹤0.01% | 6359 |
|
|
2024
Q4 | $112K | Buy |
85,802
+85,798
| +2,144,950% | +$112K | ﹤0.01% | 4732 |
|
|
2024
Q3 | $14 | Hold |
4
| – | – | ﹤0.01% | 6204 |
|
|
2024
Q2 | $13 | Hold |
4
| – | – | ﹤0.01% | 6171 |
|
|
2024
Q1 | $19 | Hold |
4
| – | – | ﹤0.01% | 6161 |
|
|
2023
Q4 | $29 | Sell |
4
-8,147
| -100% | -$59.1K | ﹤0.01% | 6244 |
|
|
2023
Q3 | $98.5K | Buy |
8,151
+6,633
| +437% | +$80.1K | ﹤0.01% | 4609 |
|
|
2023
Q2 | $16.1K | Buy |
1,518
+39
| +3% | +$413 | ﹤0.01% | 5084 |
|
|
2023
Q1 | $15K | Buy |
1,479
+29
| +2% | +$294 | ﹤0.01% | 5200 |
|
|
2022
Q4 | $21K | Sell |
1,450
-21,771
| -94% | -$315K | ﹤0.01% | 4963 |
|
|
2022
Q3 | $282K | Buy |
23,221
+1,046
| +5% | +$12.7K | ﹤0.01% | 4021 |
|
|
2022
Q2 | $311K | Sell |
22,175
-2,864
| -11% | -$40.2K | ﹤0.01% | 4118 |
|
|
2022
Q1 | $356K | Buy |
25,039
+1,253
| +5% | +$17.8K | ﹤0.01% | 4169 |
|
|
2021
Q4 | $502K | Sell |
23,786
-4,768
| -17% | -$101K | ﹤0.01% | 4054 |
|
|
2021
Q3 | $750K | Buy |
28,554
+26,765
| +1,496% | +$703K | ﹤0.01% | 3765 |
|
|
2021
Q2 | $56K | Sell |
1,789
-182,688
| -99% | -$5.72M | ﹤0.01% | 4915 |
|
|
2021
Q1 | $5.66M | Buy |
184,477
+184,450
| +683,148% | +$5.66M | ﹤0.01% | 2555 |
|
|
2020
Q4 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 4830 |
|